Floatz logo

Retrovir

Nutritional Deficiency Disease

International Maternal Pediatric Adolescent AIDS Clinical Trials GroupSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Nutritional Deficiency Disease cohort.

Asset / SponsorPhaseRating
Methoxy Polyethylene Glycol-Epoetin Beta
Taipei Veterans General Hospital, Taiwan
Phase 4BB
Intralipid
Johane Allard
Phase 4BB
Guanfacine
Maimonides Medical Center
Phase 4BB
Lamivudine
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BB
Thalidomide
Chinese University of Hong Kong
Phase 4BB

View all 31 →

Same molecule, other indications

Retrovir is also rated in:

HIV infectious diseaseDormant
BBB
Indicative · Phase 4
77 / 100
View asset →
lipodystrophyDormant
BBB
Indicative · Phase 4
76 / 100
View asset →
cardiovascular disorderDormant
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →